Much research has focused on the basic cellular and molecular biological aspects of stem cells. Much of this research has been fueled by their potential for use in regenerative medicine applications, which has in turn spurred growing numbers of translational and clinical studies. However, more work is needed if the potential is to be realized for improvement of the lives and well-being of patients with numerous diseases and conditions.

This book series 'Cell Biology and Translational Medicine (CBTMED)' as part of Springer Nature's longstanding and very successful Advances in Experimental Medicine and Biology book series, has the goal to accelerate advances by timely information exchange. Emerging areas of regenerative medicine and translational aspects of stem cells are covered in each volume. Outstanding researchers are recruited to highlight developments and remaining challenges in both the basic research and clinical arenas. This current book is the 14th volume of a continuing series.

Recent Advances in the Generation of beta-cells from Induced Pluripotent Stem Cells As a Potential Cure for Diabetes Mellitus

Differentiated cells derived from hematopoietic stem cells and their applications in translational medicine
Organoids in Tissue Transplantation
Aldo keto reductases AKR1B1 and AKR1B10 in cancer: molecular mechanisms and signaling networks
Bilayer Scaffolds for Interface Tissue Engineering and regenerative medicine: A Systematic Review
Pluripotent Stem Cell Derived Neurons as In Vitro Models for Studying Autosomal Recessive Parkinson's Disease (ARPD): PLA2G6 and Other Gene Loci
Stem Cell Applications In Lysosomal Storage Disorders: Progress And Ongoing Challenges
Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers
Telomere length and oxidative stress in patients with St-elevation and Non-St-elevation myocardial infarction
Eosinophils as major player in Type 2 inflammation: autoimmunity and beyond.